secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001104659-23-074450
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure adopts amended bylaws, elects three directors, ratifies auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Bylaws amended June 22, 2023 to incorporate Delaware law updates and universal proxy rule requirements.
- Stockholders elected Class I directors Anne Borgman, John G. Houston, and Garry A. Nicholson.
- Ratified Ernst & Young as independent auditor for fiscal year ending Dec 31, 2023 (19.67M for, 155k against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/0001104659-23-074450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000110465923074450/tm2319533d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-074450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer